4//SEC Filing
Van Vliet David A 4
Accession 0001140361-09-001328
CIK 0000057055other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 5:46 PM ET
Size
12.2 KB
Accession
0001140361-09-001328
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
Van Vliet David A
Interim Pres./ Interim CEO, KV
Transactions
- Award
Option to Purchase
2009-01-13+150,000→ 150,000 totalExercise: $2.95Exp: 2019-01-13→ Class A Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option vests in three installments: 33% on January 13, 2010, 33% on January 13, 2011 and 34% on January 13, 2012.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeother
Related Parties
1- filerCIK 0001296310
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 5:46 PM ET
- Size
- 12.2 KB